Anatomical Therapeutic Chemical • M05BX04 • denosumab

M Musculo-skeletal system

M01 Antiinflammatory and antirheumatic products

M02 Topical products for joint and muscular pain

M03 Muscle relaxants

M04 Antigout preparations

M05 Drugs for treatment of bone diseases

M05B Drugs affecting bone structure and mineralization

M05BA Bisphosphonates

M05BB Bisphosphonates, combinations

M05BC Bone morphogenetic proteins

M05BX Other drugs affecting bone structure and mineralization

M05BX03 strontium ranelat Indicated for: osteoporosis

M05BX04 denosumab Indicated for: osteoporosis; bone metastases; tumor-induced hypercalcemia

M05BX05 burosumab Indicated for: X-linked hypophosphatemia

M05BX06 romosozumab Indicated for: osteoporosis

M05BX07 vosoritid Indicated for: achondroplasia

M09 Other drugs for disorders of the musculo-skeletal system